Treatment

Hoffmann-La Roche: Pricing the Zelboraf Melanoma Treatment for Canada Case Solution

Case Solution & Analysis for Hoffmann-La Roche: Pricing the Zelboraf Melanoma Treatment for Canada by Mark Zbaracki, Jedy Wang.

Complete Case details are given below :

Case Name :      Hoffmann-La Roche: Pricing the Zelboraf Melanoma Treatment for Canada
Authors :           Mark Zbaracki, Jedy Wang
Source :              Ivey Publishing
Case ID :           9B16M138 / W16552
Discipline :        General Management
Case Length :    12 pages
Plagiarism : NO (100% Original work)
Description for case is given below :
The Canadian brand manager of Zelboraf had to decide how to introduce and price Zelboraf in the Canadian market. Zelboraf was a breakthrough discovery in treatment for melanoma cancer patients. Hoffmann-La Roche (Roche) began developing Zelboraf in 2005. During the clinical trials, the drug yielded such positive results in targeting late-stage (metastatic) melanoma cancer that Roche ended clinical trials early in order to expedite FDA approval and market launch. A competitor was developing a drug-Dabrafenib-that targeted the same segment of patients with B-RAF genes. It was unclear if this specific market segment could support two similar products. It was also unclear whether Dabrafenib’s Canadian market launch would affect the likelihood that Zelboraf got on the approved drug list to secure government reimbursement. The brand manager and her team also needed to determine the right price point for Zelboraf. Roche had to set a price that ensured profitability, but did not compromise Zelboraf’s competitive position.
 
Click Here to place your order
 
OR
Place your order at casesolutionshub (AT)gmail(dot)com if you want to solve above case.
 
Cordially,
Case Solutions Hub Team
Advertisement

Case Solution for Spinal Cord Injury Treatment

Complete Case details are given below :

Case Name :      Spinal Cord Injury Treatment
Authors :           Elizabeth M.A. Grasby, David House
Source :             Ivey Publishing
Case ID :            907M18
Discipline :        Social Enterprise
Case Length :    12 pages
Solution Sample availability : YES
Plagiarism : NO (100% Original work)
Description for case is given below :
A research team has discovered a treatment to reduce the severity of spinal cord injuries and improve the injured victim’s long-term quality of life. The director of the team fears that the biopharmaceutical company that owns the patent for the antibody used in the treatment will not pursue the development of this application, and she must develop a strategy to garner the firm’s support. If the patent holder chooses not to move forward with the treatment, the director has the option to continue development herself, but she is not convinced she has the business skills to do so. Students consider the ethical dilemma of balancing the necessity of a business to generate profits for its investors with the needs of society.
 
Click Here to place your order
 
OR
Place your order at casesolutionshub (AT)gmail(dot)com if you want to solve above case.
 
Cordially,
Case Solutions Hub

Case Solution for Monsanto and the Global Water Treatment Industry
Complete Case details are given below :
Case Name :      Monsanto and the Global Water Treatment Industry
Authors :           Mary M. Crossan, Dusya Vera
Source :             Ivey Publishing
Case ID :            99M040
Discipline :        Strategy
Case Length :    21 pages
Solution Sample availability : YES
Plagiarism : NO (100% Original work)
Description for case is given below :
Monsanto, a biotechnology giant highly committed to sustainable development efforts, needs to assess the attractiveness of the drinking water treatment industry before deciding its entry to it. Four dimensions of the global water treatment industry are described: types of products and services, applications, end users, and geographical markets. The drinking water treatment segment, which is classified into municipal drinking water treatment and residential drinking water treatment, is examined in depth. Players in these two categories produce the chemicals and equipment necessary to purify tap water supplied to consumers and residential water purification devices. The bottled water industry is considered a substitute of the drinking water treatment segment. Teaching purpose: To answer the question “Is the industry attractive?” and to introduce students to industry analysis and industry segmentation.
 
Click Here to place your order
 
OR
Place your order at casesolutionshub (AT)gmail(dot)com if you want to solve above case.
 
Cordially,
Case Solutions Hub